In a major development in the COVID medicine field, Glenmark Pharmaceuticals said that it will be conducting a Phase III trial on a nasal spray claiming to be effective in the treatment of COVID-19. Earlier last week, the company had sought emergency approval for the import and marketing of the nasal spray from the drug regulator. The pharma company has now been recommended to hold phase III trials by the authorities.
Register here.